BACKGROUND AND PURPOSE: Based on an experimental model of warfarin-associated intracerebral hemorrhage, we investigated whether the rapid reversal of anticoagulation using prothrombin complex concentrates (PCC) or recombinant activated coagulation factor VII (rFVIIa) reduces hematoma volume. METHODS: Mice were orally pretreated with warfarin (2 mg/kg). Intracerebral hemorrhage was induced by collagenase injection into the right striatum. Forty-five minutes later, PCC (100 IE/kg), rFVIIa (1 mg/kg), or an equal volume of saline was administered intravenously. Hematoma volume after 24 hours was quantified using a photometric hemoglobin assay. RESULTS: International normalized ratio was 4.3±0.4 in saline-treated mice, 0.9±0.1 in rFVIIa mice, and 1.4±0.2 in PCC mice. Intracerebral hemorrhage volume was 29.0±19.7 μL in the saline group (n=7), 8.6±4.3 μL in the rFVIIa group (n=6), and 6.1±1.8 μL in the PCC group (n=7; analysis of variance between-group differences P=0.004; post hoc rFVIIa versus saline P=0.021; PCC versus saline P=0.007). No significant difference was found between PCC- and rFVIIa-treated animals. CONCLUSIONS: Our results suggest that PCC and rFVIIa are equally effective in restoring coagulation and preventing excessive hematoma growth in acute warfarin-associated intracerebral hemorrhage.
BACKGROUND AND PURPOSE: Based on an experimental model of warfarin-associated intracerebral hemorrhage, we investigated whether the rapid reversal of anticoagulation using prothrombin complex concentrates (PCC) or recombinant activated coagulation factor VII (rFVIIa) reduces hematoma volume. METHODS:Mice were orally pretreated with warfarin (2 mg/kg). Intracerebral hemorrhage was induced by collagenase injection into the right striatum. Forty-five minutes later, PCC (100 IE/kg), rFVIIa (1 mg/kg), or an equal volume of saline was administered intravenously. Hematoma volume after 24 hours was quantified using a photometric hemoglobin assay. RESULTS: International normalized ratio was 4.3±0.4 in saline-treated mice, 0.9±0.1 in rFVIIa mice, and 1.4±0.2 in PCC mice. Intracerebral hemorrhage volume was 29.0±19.7 μL in the saline group (n=7), 8.6±4.3 μL in the rFVIIa group (n=6), and 6.1±1.8 μL in the PCC group (n=7; analysis of variance between-group differences P=0.004; post hoc rFVIIa versus saline P=0.021; PCC versus saline P=0.007). No significant difference was found between PCC- and rFVIIa-treated animals. CONCLUSIONS: Our results suggest that PCC and rFVIIa are equally effective in restoring coagulation and preventing excessive hematoma growth in acute warfarin-associated intracerebral hemorrhage.
Authors: William D Freeman; Thomas G Brott; Kevin M Barrett; Pablo R Castillo; H Gordon Deen; Leo F Czervionke; James F Meschia Journal: Mayo Clin Proc Date: 2004-12 Impact factor: 7.616
Authors: Maria I Aguilar; Robert G Hart; Carlos S Kase; William D Freeman; Barbara J Hoeben; Rosa C García; Jack E Ansell; Stephan A Mayer; Bo Norrving; Jonathan Rosand; Thorsten Steiner; Eelco F M Wijdicks; Takenori Yamaguchi; Masahiro Yasaka Journal: Mayo Clin Proc Date: 2007-01 Impact factor: 7.616
Authors: Christian Foerch; Ken Arai; Elizabeth Merrill Van Cott; Klaus van Leyen; Eng H Lo Journal: J Cereb Blood Flow Metab Date: 2009-03-25 Impact factor: 6.200
Authors: Christian Foerch; Ken Arai; Guang Jin; Kyung-Pil Park; Stefanie Pallast; Klaus van Leyen; Eng H Lo Journal: Stroke Date: 2008-09-04 Impact factor: 7.914
Authors: Frieder Schlunk; Elena Schulz; Arne Lauer; Kazim Yigitkanli; Waltraud Pfeilschifter; Helmuth Steinmetz; Eng H Lo; Christian Foerch Journal: Transl Stroke Res Date: 2014-11-27 Impact factor: 6.829
Authors: Frieder Schlunk; Maximilian Böhm; Gregoire Boulouis; Tao Qin; Michal Arbel; Isra Tamim; Paul Fischer; Brian J Bacskai; Matthew P Frosch; Matthias Endres; Steven M Greenberg; Cenk Ayata Journal: Stroke Date: 2019-05 Impact factor: 7.914
Authors: Arne Lauer; Waltraud Pfeilschifter; Chris B Schaffer; Eng H Lo; Christian Foerch Journal: Lancet Neurol Date: 2013-03-18 Impact factor: 44.182